Evidence map›Paper›PMID 37582777›Full record

ArticleNature communications2023

mRNA 3'UTR lengthening by alternative polyadenylation attenuates inflammatory responses and correlates with virulence of Influenza A virus.

Valter Bergant, Daniel Schnepf, Niklas de Andrade Krätzig, Philipp Hubel, Christian Urban, Thomas Engleitner, Ronald Dijkman, Bernhard Ryffel, Katja Steiger, Percy A Knolle and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 4 countries.

Valter BergantInstitute of Virology, TUM School of Medicine, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0003-3458-9506
Daniel SchnepfInstitute of Virology, Medical Center University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0002-7528-981X
Niklas de Andrade KrätzigInstitute of Molecular Oncology and Functional Genomics, TUM School of Medicine, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0003-2141-6745
Philipp HubelMax Planck Institute of Biochemistry, Munich, Germany.
Christian UrbanInstitute of Virology, TUM School of Medicine, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-4080-2468
Thomas EngleitnerInstitute of Molecular Oncology and Functional Genomics, TUM School of Medicine, Technical University of Munich, Munich, Germany.
Ronald DijkmanInstitute for Infectious Diseases, University of Bern, Bern, Switzerland.
Bernhard RyffelCNRS, UMR7355, Orleans, France.ORCID http://orcid.org/0000-0003-2897-8230
Katja SteigerInstitut für allgemeine Pathologie und Pathologische Anatomie, TUM School of Medicine, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-7269-5433
Percy A KnolleInstitute of Molecular Immunology and Experimental Oncology, TUM School of Medicine, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0003-2983-0414
Georg KochsInstitute of Virology, Medical Center University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0003-0187-559X
Roland RadInstitute of Molecular Oncology and Functional Genomics, TUM School of Medicine, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-6849-9659
Peter StaeheliInstitute of Virology, Medical Center University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0001-7057-6177
Andreas PichlmairInstitute of Virology, TUM School of Medicine, Technical University of Munich, Munich, Germany. andreas.pichlmair@tum.de.ORCID http://orcid.org/0000-0002-0166-1367
Technical University of Munich · DEMax Planck Institute of Psychiatry · DEUniversity of Freiburg · DEGerman Center for Infection Research · DEUniversité d'Orléans · FRUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Changes of mRNA 3'UTRs by alternative polyadenylation (APA) have been associated to numerous pathologies, but the mechanisms and consequences often remain enigmatic. By combining transcriptomics, proteomics and recombinant viruses we show that all tested strains of IAV, including A/PR/8/34(H1N1) (PR8) and A/Cal/07/2009 (H1N1) (Cal09), cause APA. We mapped the effect to the highly conserved glycine residue at position 184 (G184) of the viral non-structural protein 1 (NS1). Unbiased mass spectrometry-based analyses indicate that NS1 causes APA by perturbing the function of CPSF4 and that this function is unrelated to virus-induced transcriptional shutoff. Accordingly, IAV strain PR8, expressing an NS1 variant with weak CPSF binding, does not induce host shutoff but only APA. However, recombinant IAV (PR8) expressing NS1(G184R) lacks binding to CPSF4 and thereby also the ability to cause APA. Functionally, the impaired ability to induce APA leads to an increased inflammatory cytokine production and an attenuated phenotype in a mouse infection model. Investigating diverse viral infection models showed that APA induction is a frequent ability of many pathogens. Collectively, we propose that targeting of the CPSF complex, leading to widespread alternative polyadenylation of host transcripts, constitutes a general immunevasion mechanism employed by a variety of pathogenic viruses.

Indexed as

Influenza A virusInfluenza A Virus, H1N1 Subtype3' Untranslated RegionsAnimalsMicePolyadenylationViral Nonstructural ProteinsVirulence3' Untranslated RegionsViral Nonstructural Proteins

Identifiers

PMID37582777
PMCPMC10427651
OpenAlexW4385837237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.